Aequus Pharmaceuticals Inc (AQS) — Cash Flow Reinvestment Rate
Latest as of March 2025:
0.00x
Aequus Pharmaceuticals Inc (AQS) has a Cash Flow Reinvestment Rate of 0.00x as of March 2025, reinvesting CA$0.00 (capex CA$0.00 ) from operating cash flow of CA$31.71K. See AQS free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
0.00x
(Capex + Investments) / Operating CF
Total Reinvested
CA$0.00
Capex + Investments
Operating Cash Flow
CA$31.71K
CAD
Capital Expenditures
CA$0.00
CAD
Annual Cash Flow Reinvestment Rate for Aequus Pharmaceuticals Inc (None–None)
Year-by-year capital reinvestment analysis for Aequus Pharmaceuticals Inc. See Aequus Pharmaceuticals Inc (AQS) financial flexibility to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (CAD) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow